Incidence of Benign Renal Masses in a Contemporary Cohort of Patients Receiving Partial Nephrectomy for Presumed Renal Cell Carcinoma

Published:November 17, 2022DOI:


      • Despite the rising use of renal mass biopsy, the incidence of benign renal masses resected for oncologic indications has remained stable.
      • Oncocytoma poses the most significant diagnostic challenge in attempting to differentiate RCC from benign masses.
      • Smaller tumor size is predictive of finding benign pathology after extirpative surgery.



      Over the past decade and a half, advances in diagnostic imaging as well as an increased utilization of active surveillance (AS) and renal mass biopsy (RMB) have led to an improved ability to identify benign lesions prior to partial nephrectomy (PN). We seek to examine the incidence of benign pathology at the time of PN in a contemporary cohort of patients undergoing PN for presumed renal cell carcinoma (RCC).

      Patients and Methods

      We performed a chart review on a prospectively maintained database on a series of patients who underwent PN between January 1, 2006 and December 31, 2021 for solid renal masses concerning for RCC.


      One thousand two hundred twenty-nine patients were included in the analysis, with 240 patients (19.2%) identified to have benign disease on final pathology. Of patients with benign disease, (23%) of patients had angiomyolipoma (AML) and 64% had oncocytoma. Between 2006 and 2021, there was a significant increase in the incidence of benign pathology after PN. When examining 3-year rolling averages over this same time period, the incidence of oncocytoma appeared to increase while the incidence of AML decreased.


      Despite improvements in diagnostic tools and increased utilization of active surveillance, the overall incidence of benign pathology, particularly oncocytoma, did not decrease over time in this contemporary cohort of patients undergoing PN.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinical Genitourinary Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Hollingsworth JM.
        • et al.
        Rising incidence of small renal masses: a need to reassess treatment effect.
        J Natl Cancer Inst Monogr. 2006; 98: 1331-1334
        • Jayson Mary
        • Sanders Holt
        Increased incidence of serendipitously discovered renal cell carcinoma.
        Urology. 1998; 51: 203-205
        • Huang William C.
        • et al.
        Partial nephrectomy versus radical nephrectomy in patients with small renal tumors—is there a difference in mortality and cardiovascular outcomes?.
        J Urol. 2009; 181: 55-62
        • Znaor Ariana
        • et al.
        International variations and trends in renal cell carcinoma incidence and mortality.
        Eur Urol. 2015; 67: 519-530
        • Mason Ross J.
        • et al.
        Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance.
        Eur Urol. 2011; 59: 863-867
        • Ristau Benjamin T.
        • et al.
        Active surveillance for small renal masses: when less is more.
        Eur Urol Focus. 2016; 2: 660-668
        • Patel Nilay
        • et al.
        Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy.
        BJU Int. 2012; 110: 1270-1275
        • Danzig Matthew R.
        • et al.
        Active surveillance is superior to radical nephrectomy and equivalent to partial nephrectomy for preserving renal function in patients with small renal masses: results from the DISSRM registry.
        J Urol. 2015; 194: 903-909
        • Kutikov Alexander
        • et al.
        Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging.
        Urology. 2006; 68: 737-740
        • Kim Jae Heon
        • et al.
        Association of prevalence of benign pathologic findings after partial nephrectomy with preoperative imaging patterns in the United States from 2007 to 2014.
        JAMA Surg. 2019; 154: 225-231
        • Wilson Mitchell P.
        • et al.
        Diagnostic Performance of MRI in the Detection of Renal Lipid-Poor Angiomyolipomas: A Systematic Review and Meta-Analysis.
        Radiology. 2020; 296: 511-520
        • Choudhary S.
        • et al.
        Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasms.
        Clin Radiol. 2009; 64: 517-522
        • Rosenkrantz Andrew B.
        • et al.
        MRI features of renal oncocytoma and chromophobe renal cell carcinoma.
        AJR Am J Roentgenol. 2010; 195: W421-W427
        • Fujii Yasuhisa
        • et al.
        Incidence of benign pathologic lesions at partial nephrectomy for presumed RCC renal masses: Japanese dual-center experience with 176 consecutive patients.
        Urology. 2008; 72: 598-602
        • Bauman Tyler M.
        • et al.
        Partial nephrectomy for presumed renal-cell carcinoma: incidence, predictors, and perioperative outcomes of benign lesions.
        J Endourol. 2017; 31: 412-417
        • Jeon Hwang Gyun
        • et al.
        Benign lesions after partial nephrectomy for presumed renal cell carcinoma in masses 4 cm or less: prevalence and predictors in Korean patients.
        Urology. 2010; 76: 574-579
        • Oh Sang Woo
        • Yoon Yeong Sook
        • Shin Soon-Ae
        Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study.
        J Clin Oncol. 2005; 23: 4742-4754
        • Murphy Alana M.
        • et al.
        Increasing detection rate of benign renal tumors: evaluation of factors predicting for benign tumor histologic features during past two decades.
        Urology. 2009; 73: 1293-1297
        • Snyder Mark E.
        • et al.
        Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex.
        J Urol. 2006; 176: 2391-2396
        • Lim Robert S.
        • et al.
        Renal angiomyolipoma without visible fat: Can we make the diagnosis using CT and MRI?.
        Eur Radiol. 2018; 28: 542-553
        • Yang Ching-Wei
        • et al.
        Are there useful CT features to differentiate renal cell carcinoma from lipid-poor renal angiomyolipoma?.
        AJR Am J Roentgenol. 2013; 201: 1017-1028
        • Hafron Jason
        • et al.
        Imaging characteristics of minimal fat renal angiomyolipoma with histologic correlations.
        Urology. 2005; 66: 1155-1159
        • Hajdu Steven I.
        • Foote Frank W.
        Angiomyolipoma of the kidney: report of 27 cases and review of the literature.
        J Urol. 1969; 102: 396-401
        • Remzi Mesut
        • et al.
        Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter.
        J Urol. 2006; 176: 896-899
        • Schachter Lee R.
        • et al.
        Second prize: frequency of benign renal cortical tumors and histologic subtypes based on size in a contemporary series: what to tell our patients.
        J Endourol. 2007; 21: 819-823
        • Johnson NB
        • Johnson MM
        • Selig MK
        • Nielsen GP.
        Use of electron microscopy in core biopsy diagnosis of oncocytic renal tumors.
        Ultrastruct Pathol. 2010; l34: 189-194
        • Carvalho PA
        • Chiu ML
        • Kronauge JF.
        Subcellar distribution and analysis of technetium-99m0MIBI in isolated perfused rat hearts.
        J Nuc Med. 1992; 33: 1516-1522
        • Wilson Mitchell P.
        • et al.
        Diagnostic accuracy of 99mTc-sestamibi SPECT/CT for detecting renal oncocytomas and other benign renal lesions: a systematic review and meta-analysis.
        Abdom Radiol. 2020; 45: 2532-2541
        • Schieda N
        • Al-Subhi M
        • Flood TA
        • El-Khodary M
        • McInnes MD.
        Diagnostic accuracy of segmental enhancement inversion for the diagnosis of renal oncocytoma using biphasic computed tomography (CT) and multiphase contrast-enhanced magnetic resonance imaging (MRI).
        Eur Radiol. 2014; 24: 2787-2794